Predict your next investment

Venture Capital
kensonventures.com

See what CB Insights has to offer

Investments

21

Portfolio Exits

3

About Kenson Ventures

Kenson Ventures provides seed money/funds and strategic advice to start-ups, partnerships, and established companies focusing in the biotechnology and life science areas. Kenson Ventures also considers and participates in co-investment with other institutions.

Kenson Ventures Headquarter Location

400 Hamilton Avenue

Palo Alto, California, 94301-1834,

United States

650-330-0322

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kenson Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Kenson Ventures in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Kenson Ventures Investments

21 Investments

Kenson Ventures has made 21 investments. Their latest investment was in GB Lifesciences as part of their Series B on May 5, 2018.

CBI Logo

Kenson Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/16/2018

Series B

GB Lifesciences

$5.18M

No

1

3/21/2016

Series B

Turning Point Therapeutics

$18M

Yes

1

6/18/2015

Series C

Advanced Cell Diagnostics

$22M

Yes

3

8/7/2013

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/24/2012

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/16/2018

3/21/2016

6/18/2015

8/7/2013

10/24/2012

Round

Series B

Series B

Series C

Series A

Series A

Company

GB Lifesciences

Turning Point Therapeutics

Advanced Cell Diagnostics

Subscribe to see more

Subscribe to see more

Amount

$5.18M

$18M

$22M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

3

10

10

Kenson Ventures Portfolio Exits

3 Portfolio Exits

Kenson Ventures has 3 portfolio exits. Their latest portfolio exit was Turning Point Therapeutics on April 17, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/17/2019

IPO

$991

4

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

4/17/2019

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

10

10

Kenson Ventures Team

1 Team Member

Kenson Ventures has 1 team member, including undefined undefined, undefined.

Name

Work History

Title

Status

Kenneth Fong

Founder

Current

Name

Kenneth Fong

Work History

Title

Founder

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.